IS8223A - Afleiður naftalens sem tálmar sýtókróms P-450 - Google Patents

Afleiður naftalens sem tálmar sýtókróms P-450

Info

Publication number
IS8223A
IS8223A IS8223A IS8223A IS8223A IS 8223 A IS8223 A IS 8223A IS 8223 A IS8223 A IS 8223A IS 8223 A IS8223 A IS 8223A IS 8223 A IS8223 A IS 8223A
Authority
IS
Iceland
Prior art keywords
naphthalene derivatives
inhibit cytochrome
cytochrome
inhibit
naphthalene
Prior art date
Application number
IS8223A
Other languages
English (en)
Inventor
Smith Vanessa
Nigro Anthony
Mulvihill Mark
Cesario Cara
Anne Beck Patricia
Lucas Castelhano Arlindo
Original Assignee
Osi Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osi Pharmaceuticals, Inc. filed Critical Osi Pharmaceuticals, Inc.
Publication of IS8223A publication Critical patent/IS8223A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
IS8223A 2003-07-10 2006-01-10 Afleiður naftalens sem tálmar sýtókróms P-450 IS8223A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48638203P 2003-07-10 2003-07-10
PCT/US2004/022282 WO2005007631A1 (en) 2003-07-10 2004-07-12 Naphthylene derivatives as cytochrome p450 inhibitors

Publications (1)

Publication Number Publication Date
IS8223A true IS8223A (is) 2006-01-10

Family

ID=34079229

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8223A IS8223A (is) 2003-07-10 2006-01-10 Afleiður naftalens sem tálmar sýtókróms P-450

Country Status (15)

Country Link
EP (1) EP1654236A1 (is)
JP (1) JP4832295B2 (is)
KR (1) KR20060052799A (is)
CN (1) CN1819996B (is)
AU (1) AU2004257257B2 (is)
BR (1) BRPI0412424A (is)
CA (1) CA2532078A1 (is)
IL (1) IL172812A0 (is)
IS (1) IS8223A (is)
MX (1) MXPA06000401A (is)
NO (1) NO20060114L (is)
RU (1) RU2363696C2 (is)
SG (1) SG144941A1 (is)
UA (1) UA87822C2 (is)
WO (1) WO2005007631A1 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1696899A1 (en) * 2003-12-17 2006-09-06 Allergan, Inc. Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b
US7662844B2 (en) 2004-07-12 2010-02-16 Osi Pharmaceuticals, Inc. Naphthylene derivatives as cytochrome P450 inhibitors
US8513291B2 (en) 2010-06-01 2013-08-20 Angion Biomedica Corp. Cytochrome P450 inhibitors and uses thereof
US10414760B2 (en) 2016-11-29 2019-09-17 Angion Biomedica Corp. Cytochrome P450 inhibitors and uses thereof
KR20180039185A (ko) * 2010-11-13 2018-04-17 이노크린 파마슈티컬즈, 인크. 금속효소 억제제 화합물
EP2651905B1 (en) * 2010-12-13 2017-07-19 Innocrin Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基
WO2014015137A2 (en) * 2012-07-18 2014-01-23 Angion Biomedica Corp. Compositions and methods for treating dysproliferative diseases
AU2015301891B2 (en) 2014-08-11 2019-12-05 Angion Biomedica Corporation Cytochrome P450 inhibitors and uses thereof
CN104523967B (zh) * 2014-12-12 2017-08-01 扬子江药业集团北京海燕药业有限公司 一种柏艾胶囊作为cyp酶抑制剂的应用
AU2015374231B2 (en) 2014-12-31 2020-07-23 Angion Biomedica Corp. Methods and agents for treating disease
GB201602572D0 (en) * 2016-02-12 2016-03-30 Eriksson Leif And Strid Ake And Sirsjö Allan New compound and uses
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz
EP3568395A1 (de) 2017-01-10 2019-11-20 Bayer Aktiengesellschaft Heterocyclen-derivate als schädlingsbekämpfungsmittel
TW201837036A (zh) 2017-01-10 2018-10-16 德商拜耳廠股份有限公司 作為除害劑之雜環衍生物（一）

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL291944A (is) * 1960-05-04
NL131915C (is) * 1966-07-27
DE3508903A1 (de) * 1985-03-13 1986-09-18 Hoechst Ag, 6230 Frankfurt Neue 3-pyridylmethylnaphtylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3628545A1 (de) * 1985-09-23 1987-04-23 Hoechst Ag Arylmethylazole und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
AU5285593A (en) * 1992-10-21 1994-05-09 Sankyo Company Limited Azole compound
JP4546589B2 (ja) * 1998-04-23 2010-09-15 武田薬品工業株式会社 ナフタレン誘導体
ATE293102T1 (de) * 1998-04-23 2005-04-15 Takeda Pharmaceutical Naphthalene derivate ,ihre herstellung und verwendung
FR2796070B1 (fr) * 1999-07-06 2003-02-21 Lipha Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
PE20010781A1 (es) * 1999-10-22 2001-08-08 Takeda Chemical Industries Ltd Compuestos 1-(1h-imidazol-4-il)-1-(naftil-2-sustituido)etanol, su produccion y utilizacion
JP4520012B2 (ja) * 1999-10-22 2010-08-04 武田薬品工業株式会社 １−置換−１−（１ｈ−イミダゾール−４−イル）メタノール類

Also Published As

Publication number Publication date
CN1819996B (zh) 2010-10-27
RU2363696C2 (ru) 2009-08-10
WO2005007631A1 (en) 2005-01-27
EP1654236A1 (en) 2006-05-10
KR20060052799A (ko) 2006-05-19
UA87822C2 (ru) 2009-08-25
JP4832295B2 (ja) 2011-12-07
SG144941A1 (en) 2008-08-28
MXPA06000401A (es) 2006-03-17
AU2004257257B2 (en) 2011-05-12
IL172812A0 (en) 2006-06-11
CA2532078A1 (en) 2005-01-27
CN1819996A (zh) 2006-08-16
BRPI0412424A (pt) 2006-09-05
RU2006103996A (ru) 2006-07-10
NO20060114L (no) 2006-02-09
JP2007523866A (ja) 2007-08-23
AU2004257257A1 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
IS8223A (is) Afleiður naftalens sem tálmar sýtókróms P-450
DE602005002886D1 (de) Kopfhörerantenne
ATA1542003A (de) Kopfhörer
ATA1532003A (de) Kopfhörer
EP1812585A4 (en) BACTERIOPHAGES AS SELECTIVE AGENTS
EG24509A (en) Substituted isoxazoles as fungicides
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
PL1755593T3 (pl) Pochodne naftalenu przydatne jako ligandy 3-receptora histaminowego
EP1739485A4 (en) RESISTANT COMPOSITION
DE112004001751D2 (de) Socke
EP1810965A4 (en) HYDRAZIDE DERIVATIVES
EP1833497A4 (en) BACTERIOPHAGE COMPOSITIONS
GB0704024D0 (en) Expandable tubular
IS8273A (is) Nýr búnaður
DE112004002437D2 (de) Socke
GB2432605B (en) Expandable tubular
DE602005018177D1 (de) Drehzerstäubungskopf-lackiervorrichtung
DE502006002227D1 (de) Bürogerät
FI20041057A0 (fi) Pelkistysainekoostumus
DK1778265T3 (da) Guanylhydrazoneforbindelser, sammensætninger, fremgangsmåder og anvendelse
DE50303106D1 (de) Aufwickler
TWI315998B (en) Organic halogen compound decomposing agent
DE502005006568D1 (de) Entstörvorrichtung
DE60311243D1 (de) Aufwickelvorrichtung
ZA200702045B (en) Substituted isoxazoles as fungicides